Chronic hepatitis B virus (HBV) infection in pregnancy
- PMID: 19669267
- PMCID: PMC2716894
- DOI: 10.1007/s12072-008-9063-4
Chronic hepatitis B virus (HBV) infection in pregnancy
Abstract
Background: Hepatitis B is a considerable disease burden among Asians. Little is known about its disease behaviour in pregnant women.
Methods: Clinical, laboratory and radiological data of pregnant and peri-partum females with chronic hepatitis B virus (HBV) infection who were seen between years 1999 and 2004 were studied. Their progress was documented up to 6 months post-partum. This was compared with the age-matched and HBe status-matched, non-pregnant, female patients with chronic HBV infection, who were consecutively selected from the department's registry as controls (ratio 1 mother: 4 non-pregnant controls), over the corresponding period.
Results: A total of 35 mothers and 140 controls were studied. Mean age of patients was 30.7 +/- 3.6 years. Majority of mothers (74.3%) presented during pregnancy itself. 1st:2nd:3rd trimester presentation = 20.0%:48.6%:5.7%. Majority (65.7%) were positive for HBe antigen (HBeAg) at the time of presentation. About 57.1% mothers had a clinical event in the form of alanine transferase (ALT) elevation and/or loss of HBeAg vs 28.8% among controls (P = 0.002). Among HBeAg-positive subjects, more mothers (14.3%) than controls (2.2%) had resultant HBeAg loss (P = 0.02). Among HBeAg negative subjects, more mothers than controls had serum ALT elevations in the post-partum period (P = 0.007). Overall, more mothers had elevated ALT levels than controls, regardless of their HBeAg status. Neither mothers nor control subjects decompensated clinically, neither required liver transplantation nor died during the study period.
Conclusions: Pregnancy is associated with serum ALT elevation and HBeAg loss in patients with chronic HBV infection in the peri-partum period.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1136/bmj.38719.435833.7C', 'is_inner': False, 'url': 'https://doi.org/10.1136/bmj.38719.435833.7c'}, {'type': 'PMC', 'value': 'PMC1363909', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1363909/'}, {'type': 'PubMed', 'value': '16443611', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16443611/'}]}
- Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006;332(7537):328–36. - PMC - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1055/s-2003-37583', 'is_inner': False, 'url': 'https://doi.org/10.1055/s-2003-37583'}, {'type': 'PubMed', 'value': '12616449', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12616449/'}]}
- Alter MJ. Epidemiology and prevention of hepatitis B. Semin Liver Dis 2003;23(1):39–46. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00005721-199809000-00006', 'is_inner': False, 'url': 'https://doi.org/10.1097/00005721-199809000-00006'}, {'type': 'PubMed', 'value': '9747087', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9747087/'}]}
- Corrarino JE. Perinatal hepatitis B: update and recommendations. MCN Am J Matern Child Nurs 1998;23(5):246–52. - PubMed
-
- Reece SM. Immunization strategies for the elimination of hepatitis B. Nurse Pract 1993;18(2):42–5, 49–50. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1535724', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1535724/'}, {'type': 'PubMed', 'value': '2070561', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2070561/'}]}
- Mattsson R, Mattsson A, Holmdahl R, Whyte A, Rook GA. Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis. Clin Exp Immunol 1991;85(1):41–7. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
